Close Menu

NEW YORK (GenomeWeb) – OncoCyte said today that it has applied for CLIA lab certification, moving it closer to the objective of launching a lung cancer diagnostic test — its first commercial product — in the second half of 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.